ArticleJournal for immunotherapy of cancer2023

IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models.

Marjolein C Stip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.